Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer.
Lin Y, Liu Y, Gao Z, Jing D, Bi R, Cui X, Cao Q, Zhao Q, Gao R, Su Y, Liu S, Zhao M, Yang Y, Chen A, Dai B, Gao X.
Lin Y, et al. Among authors: gao x, gao z, gao r.
Eur J Pharmacol. 2023 Jun 15;949:175718. doi: 10.1016/j.ejphar.2023.175718. Epub 2023 Apr 11.
Eur J Pharmacol. 2023.
PMID: 37054937